Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 USD | +4.00% |
|
-.--% | -.--% |
06-19 | Transcript : Santhera Pharmaceuticals Holding AG - Special Call | |
06-18 | Santhera Secures CHF69 Million Financing for Bond Repayment, Cash Runway Extension | MT |
Business Summary
Number of employees: 45
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Specialty Niche Products
100.0
%
| 7 | 100.0 % | 103 | 100.0 % | +1,283.84% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
94.9
%
| - | - | 98 | 94.9 % | - |
Europe
3.3
%
| -4 | -49.7 % | 3 | 3.3 % | -191.53% |
Asia
1.9
%
| 11 | 149.7 % | 2 | 1.9 % | -82.83% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dario Eklund
CEO | Chief Executive Officer | 56 | 19-11-30 |
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Andrew Smith
DFI | Director of Finance/CFO | 61 | 20-03-31 |
Marc Schrader
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-31 |
Shabir Hasham
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Human Resources Officer | - | 22-02-28 | |
Andreas Missy
HRO | Human Resources Officer | - | 19-12-31 |
Neville Kodkani
SAM | Sales & Marketing | - | 14-12-31 |
Oliver Strub
LAW | General Counsel | 61 | 05-12-31 |
Günther Metz
PRN | Corporate Officer/Principal | 66 | 03-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Director/Board Member | 56 | 17-04-03 | |
Otto Schwarz
BRD | Director/Board Member | 68 | 23-06-26 |
Bradley Meyer
BRD | Director/Board Member | - | 23-06-26 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
2,001,327 | 15.85% | 21,895,578 $ |
Company contact information
Santhera Pharmaceuticals Holding AG
Hohenrainstrasse 24
4133, Pratteln
+41 61 906 89 50
http://www.santhera.com![address Santhera Pharmaceuticals Holding AG(SPHDF)](https://cdn.zonebourse.com/static/address/120791606.png)
Group companies
Name | Category and Sector |
---|---|
Santhera Pharmaceuticals (Switzerland) Ltd.
|
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.96% | 70.02B | |
+16.65% | 9.05B | |
-22.81% | 4.43B | |
+14.83% | 4.16B | |
+19.21% | 3.83B | |
-1.86% | 2.06B | |
+8.78% | 2.02B | |
-36.94% | 1.9B | |
-45.25% | 1.71B |
- Stock Market
- Equities
- SANN Stock
- SPHDF Stock
- Company Santhera Pharmaceuticals Holding AG